PCSK9 Inhibitors – Lipid Control

by Pravin Shukle, MD

Questions about the lecture
My Notes
  • Required.
Save Cancel
    Learning Material 2
    • PDF
      Slides LipidPharmacology CardiovascularPharma.pdf
    • PDF
      Download Lecture Overview
    Report mistake

    About the Lecture

    The lecture PCSK9 Inhibitors – Lipid Control by Pravin Shukle, MD is from the course Cardiovascular Pharmacology.

    Included Quiz Questions

    1. Clearance by the reticuloendothelial system is by a linear, non-specific pathway
    2. Clearance via the target mediated drug disposition pathway is non-saturable and non-linear
    3. They require glucuronidation in the liver before they are biologically active
    4. They are usually excreted by the kidney
    5. They are affected by drugs that affect the CYP450 system
    1. Injection site reactions
    2. Elevation of hepatic transaminases
    3. Increased hepatic triglyceride levels
    4. Increased risk of colon cancer
    5. Increased risk of renal failure
    1. Less intracellular cholesterol production
    2. Increased degradation of LDL receptor complexes
    3. Elevated levels of PCSK9
    4. Very low levels of intracellular cholesterol
    5. Decreased LDL receptor recycling.

    Author of lecture PCSK9 Inhibitors – Lipid Control

     Pravin Shukle, MD

    Pravin Shukle, MD

    Customer reviews

    5,0 of 5 stars
    5 Stars
    4 Stars
    3 Stars
    2 Stars
    1  Star
    learn new knowledge from the lecture
    By JUNJIE Z. on 16. July 2018 for PCSK9 Inhibitors – Lipid Control

    nice job! I also learn new knowledge from the profound and comprehensive lecture.